{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:41:43Z","timestamp":1791362503968,"version":"4.3.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neurobiolaging.2020.03.008","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:02:21Z","timestamp":1584428541000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6584-3111","authenticated-orcid":false,"given":"Phoebe","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole H.","family":"Sudre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassidy M.","family":"Fiford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-0348","authenticated-orcid":false,"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.neurobiolaging.2013.02.003","article-title":"Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls","volume":"34","author":"Barnes","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib3","first-page":"1","article-title":"Correction to: cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline (Alzheimer's Res. Ther. (2017) 9 DOI: 10.1186\/s13195-017-0328-9)","volume":"10","author":"Bos","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3233\/JAD-2009-1182","article-title":"Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study","volume":"18","author":"Brayne","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib5","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1109\/TMI.2015.2418298","article-title":"Geodesic information flows: Spatially-Variant Graphs and their Application to segmentation and fusion","volume":"34","author":"Cardoso","year":"2015","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib6","first-page":"2067","article-title":"[Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences]","volume":"145","author":"De Leeuw","year":"2001","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WAD.0b013e31829b72f1","article-title":"Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA)","volume":"28","author":"Esiri","year":"2014","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JAD-160474","article-title":"White matter hyperintensities potentiate hippocampal volume reduction in non-demented older individuals with abnormal amyloid-\u03b2","volume":"55","author":"Freeze","year":"2016","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nicl.2015.04.017","article-title":"The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia","volume":"8","author":"Gordon","year":"2015","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib10","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jnnp.2009.204685","article-title":"Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations","volume":"82","author":"Gouw","year":"2011","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz162","article-title":"White matter hyperintensities: relationship to amyloid and tau burden","author":"Graff-Radford","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0652-7","article-title":"Vascular pathology in the aged human brain","volume":"119","author":"Grinberg","year":"2010","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib14","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.jalz.2012.11.009","article-title":"White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment","volume":"9","author":"Guzman","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jamaneurol.2013.1878","article-title":"Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism","volume":"70","author":"Haight","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bpa.12159","article-title":"Failure of perivascular drainage of \u03b2-amyloid in cerebral amyloid angiopathy","volume":"24","author":"Hawkes","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jalz.2015.05.002","article-title":"Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2","volume":"11","author":"Jack","year":"2015","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0404.2006.00665.x","article-title":"Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism","volume":"114","author":"Jellinger","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archneur.63.5.674","article-title":"Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia","volume":"63","author":"Jicha","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/0271678X15627465","article-title":"White matter hyperintensity microstructure in amyloid dysmetabolism","volume":"37","author":"Kalheim","year":"2017","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib22","first-page":"18","article-title":"White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration","volume":"4","author":"Kandel","year":"2016","journal-title":"Alzheimer's Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","article-title":"Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers","volume":"71","author":"Kester","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib26","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1212\/WNL.0000000000000977","article-title":"Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old","volume":"83","author":"Lopez","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000002352","article-title":"Periventricular hyperintensities are associated with elevated cerebral amyloid","volume":"86","author":"Marnane","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","article-title":"Age and diagnostic performance of Alzheimer disease CSF biomarkers","volume":"78","author":"Mattsson","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40478-015-0240-0","article-title":"Cortical tau load is associated with white matter hyperintensities","volume":"3","author":"McAleese","year":"2015","journal-title":"Acta Neuropathologica Commun."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","article-title":"Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease","volume":"134","author":"McAleese","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2018.03.028","article-title":"Cerebrospinal fluid beta-amyloid42 and neurofilament light relate to white matter hyperintensities","volume":"68","author":"Osborn","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp-2017-316603","article-title":"CSF \u03b2-amyloid and white matter damage: a new perspective on Alzheimer's disease","volume":"89","author":"Pietroboni","year":"2018","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamaneurol.2013.1321","article-title":"White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?","volume":"70","author":"Provenzano","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbadis.2011.08.007","article-title":"Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants","volume":"1822","author":"Raz","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib37","first-page":"2429","article-title":"Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria","volume":"259","author":"Renard","year":"2012","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib38","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jalz.2017.01.026","article-title":"Associations between amyloid \u03b2 and white matter hyperintensities: a systematic review","volume":"13","author":"Roseborough","year":"2017","journal-title":"Alzheimer's Demen."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib39","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.neurobiolaging.2015.08.026","article-title":"Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease","volume":"36","author":"Ryan","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib40","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neurobiolaging.2016.08.014","article-title":"Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults","volume":"48","author":"Scott","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0271678X15606141","article-title":"Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment","volume":"36","author":"Shams","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib44","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib45","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels, and brain function","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke J. Cereb. Circ."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib46","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1109\/TMI.2015.2419072","article-title":"Bayesian model selection for pathological neuroimaging data applied to white matter lesion segmentation","volume":"34","author":"Sudre","year":"2015","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib47","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jalz.2015.05.014","article-title":"The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment","volume":"11","author":"Tosto","year":"2015","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib48","first-page":"1","article-title":"Cerebral white matter lesions - associations with A\u00e2 isoforms and amyloid PET","volume":"6","author":"Van Westen","year":"2016","journal-title":"Scientific Rep."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib49","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbadis.2015.09.013","article-title":"The role of cerebrovascular disease when there is concomitant Alzheimer disease","volume":"1862","author":"Vemuri","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib50","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.25071","article-title":"Age, vascular health, and Alzheimer disease biomarkers in an elderly sample","volume":"82","author":"Vemuri","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/brain\/awu393","article-title":"Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly","volume":"138","author":"Vemuri","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.21694","article-title":"Cerebrospinal fluid amyloid \u03b240 is decreased in cerebral amyloid angiopathy","volume":"66","author":"Verbeek","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-\u03b2 peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light Concentration with alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2009-1124","article-title":"Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease","volume":"18","author":"Zhou","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jmri.24550","article-title":"White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's Disease patients","volume":"41","author":"Zhou","year":"2015","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2020.03.008_bib58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:32:44Z","timestamp":1759318364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458020300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":58,"alternative-id":["S0197458020300786"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.03.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}